Europe Vaccine Logistics Market Size study, by Service (Transportation, Warehousing, Value-added Services) by End User (Hospitals, Drug Manufacturers and Distributors, Other End Users) and Country Forecasts 2022-2032
Europe Vaccine Logistics Market is valued approximately USD 655.55 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.68% over the forecast period 2024-2032. Vaccine logistics are referred to as the planning, organizing, and carrying out of tasks associated with the distribution, delivery, and storage of vaccinations. This entails employing effective transportation techniques, maintaining controlled temperature ranges through cold chain management, making sure storage facilities are sufficient, and putting appropriate labeling, packing, and inventory management procedures into place. Additionally essential to the logistics of vaccine delivery are quality control procedures and regulatory adherence. The aim is to guarantee that vaccines go to their destinations in a safe, effective, and optimum manner, supporting the effectiveness of vaccination campaigns and the outcomes for public health. The growing availability of advanced cold chain infrastructure is a key trend that is fostering the growth of the Europe Vaccine Logistics Market. Europe has a well-established cold chain infrastructure that ensures the safe handling and delivery of vaccines that require precise temperature conditions with its modern refrigerated storage facilities, temperature-controlled transportation systems, and advanced monitoring technology.
European countries have well-established national immunization programs with high vaccination rates. This necessitates a reliable and efficient logistics infrastructure to ensure consistent delivery of vaccines for routine vaccinations. Public health preparedness is a priority in Europe. Efficient vaccine logistics are crucial for rapid response to potential outbreaks or pandemics. In addition, the Europe vaccine logistics market is driven by a range of pivotal factors. Robust government support, policies, and funding for vaccination programs and public health initiatives propel the demand for efficient vaccine logistics solutions. Alongside, advancements in cold chain technology, temperature monitoring systems, and real-time tracking solutions augment the safety, reliability, and efficiency of vaccine logistics operations, stimulating market growth. The presence of a thriving pharmaceutical industry in Europe, encompassing vaccine manufacturers and biotechnology firms, further contributes to the demand for vaccine production, distribution, and logistics services. However, supply chain disruptions, transportation bottlenecks, and infrastructural constraints hinder the expansion of the regional market from 2022 to 2032.
The key countries considered for the Europe Vaccine Logistics Market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market in terms of market share. Germany boasts a well-established national immunization program with high vaccination rates, which necessitates a reliable and efficient logistics infrastructure to ensure consistent delivery of vaccines for routine vaccinations. There is a growing emphasis on developing and implementing sustainable cold chain solutions that minimize environmental impact. This involve exploring solar-powered refrigeration units or bio-degradable packaging materials. Also, the German vaccine logistics system often involves centralized procurement and distribution of vaccines. This approach necessitates efficient logistics management for nationwide distribution. Whereas, the market in UK is expected to develop at the fastest rate over the forecast period.
Major market player included in this report are:DHL Global Forwarding
DB Schenker
Kuehne + Nagel International AG
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below: By Service
Transportation
Warehousing
Value-added Services
By End User
Hospitals
Drug Manufacturers and Distributors
Other End Users
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE
Years considered for the study are as follows:Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.